| 000 | 01587 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515063200.0 | ||
| 264 | 0 | _c20071128 | |
| 008 | 200711s 0 0 eng d | ||
| 022 | _a1532-6535 | ||
| 024 | 7 |
_a10.1038/sj.clpt.6100194 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSalih, I S M | |
| 245 | 0 | 0 |
_aComparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cNov 2007 |
||
| 300 |
_a548-54 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDopamine Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Conduction System _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLong QT Syndrome _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesoridazine _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aThioridazine _xadministration & dosage |
| 700 | 1 | _aThanacoody, R H K | |
| 700 | 1 | _aMcKay, G A | |
| 700 | 1 | _aThomas, S H L | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 82 _gno. 5 _gp. 548-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.clpt.6100194 _zAvailable from publisher's website |
| 999 |
_c16962199 _d16962199 |
||